Quantcast

Latest Juvenile idiopathic arthritis Stories

2009-11-17 10:47:00

Actor Al Pacino and Gary N. Holland, M.D. Receive Prestigious Jane Wyman Humanitarian Award LOS ANGELES, Nov. 17 /PRNewswire-USNewswire/ -- The 22nd "Commitment to a Cure" Awards Gala successfully raised close to $650,000 to fund research to find a cure for arthritis, a disease affecting over 46 million adults (one in five) and nearly 300,000 children in the United States. Legendary actor Al Pacino and renowned ophthalmologist Gary N. Holland, M.D., received the prestigious Jane Wyman...

2009-06-29 12:47:02

Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk of side effects. The researchers were supported by the National Institute of Arthritis and...

2009-06-17 16:15:42

Researchers in Russia say they found stress events often preceded the onset of rheumatoid arthritis. Dr. Tatiana Lisitsyna of the State Institute of Rheumatology of the Russian Academy of Medical Sciences in Moscow also found 63 percent of those with rheumatoid arthritis also suffered psychiatric disorder -- 87 percent of these were depressive disorders. The study presented at the annual congress of the European League Against Rheumatism in Copenhagen, Denmark, also found one-third of...

2009-06-15 10:12:11

Canakinumab (ACZ885), a new interleukin-1 (IL-1)-beta blocking monoclonal antibody, shows encouraging efficacy and is well tolerated in children with systemic juvenile idiopathic arthritis (sJIA)*, according to a new phase II study presented today at PReS 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism (EULAR) in Copenhagen, Denmark.Of those patients who responded to treatment (59% of initial enrollers), 100% achieved the American College of...

2009-06-12 10:56:15

Three new studies have individually shown the anti-TNF (tumour necrosis factor) therapy etanercept to be effective, with a good safety profile, in children under four years of age with juvenile idiopathic arthritis (JIA), and associated with improved Health-Related Quality of Life (HRQoL) in a substantial proportion of children with JIA. The data are being presented at the Paediatric Rheumatology European Society Congress (PReS) 2009, a joint congress with the 2009 Congress of the European...

2009-06-12 10:11:32

Copenhagen, Denmark, Friday 12 June 2009: Patients with rheumatic diseases want more information and better communication with healthcare professionals on the sexual issues related to their conditions, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.However, a second study shows that, although nurses understand the importance of addressing sexual health with their rheumatology patients...

2009-06-11 09:24:31

Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study presented today presented today at PReS 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism (EULAR) in Copenhagen, Denmark.Effective treatment options are available to...

2009-06-09 17:01:00

- Additional data reinforce long-term efficacy of ACTEMRA across a broad range of rheumatoid arthritis patient populations - NUTLEY, N.J., June 9 /PRNewswire/ -- One-year data from the two-year Phase III LITHE (TociLIzumab Safety and THE Prevention of Structural Joint Damage) study demonstrated that a greater proportion of rheumatoid arthritis (RA) patients treated with ACTEMRA(R) (tocilizumab), a novel interleukin-6 (IL-6) receptor inhibitor, in combination with methotrexate, experienced...

2009-06-04 07:00:00

- Results of Phase III clinical studies highlight benefits of ACTEMRA as a treatment for rheumatoid arthritis - NUTLEY, N.J., June 4 /PRNewswire/ -- Roche today announced that oral and poster presentations highlighting results from the extensive multi-national ACTEMRA(R) (tocilizumab) clinical development program will be presented at the 10th Annual Congress of the European League Against Rheumatism (EULAR), which will take place June 10-13, 2009, in Copenhagen, Denmark. The studies evaluate...

2009-06-02 00:58:08

Patients suffered fewer rheumatoid arthritis symptoms when their gum disease was treated, U.S. researchers found. The study, published in the Journal of Periodontology, found treating gum disease was linked with reduced joint pain, fewer swollen joints and less morning stiffness in patients suffering from a severe form of rheumatoid arthritis. The researchers from Case Western Reserve University School of Dental Medicine and University Hospitals of Cleveland studied 40 patients with moderate...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'